Relationship between smoking-induced oxidative stress and the clinical severity of psoriasis

Journal of the European Academy of Dermatology and Venereology

Volumn 25, Issue 7, 2011, Pages 782-787

  Attwa, E ^a   Swelam, E ^b  

^a ZAGAZIG UNIVERSITY   (Egypt)

^b Zagazig University   (Egypt)

Author keywords

Oxidative stress; Psoriasis; Smoking

Indexed keywords

MALONALDEHYDE; SUPEROXIDE DISMUTASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PSORIASIS; PSORIASIS AREA SEVERITY INDEX; QUESTIONNAIRE; RECURRENT DISEASE; SKIN INFLAMMATION; SMOKING; SPECTROPHOTOMETER;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; PSORIASIS; SEVERITY OF ILLNESS INDEX; SMOKING; SUPEROXIDE DISMUTASE; YOUNG ADULT;

EID: 79955629224     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2010.03860.x     Document Type: Article

References (41)

1. Ghoreschi K, Weigert C, Röcken M. Immunopathogenesis and role of T cells in psoriasis. Clin Dermatol 2007; 25: 574-580. (Pubitemid 350087604)
2. Winterbourn CC, Hampton MB. Thiol chemistry and specificity in redox signaling. Free Rad Biol Med 2008; 45: 549-561.
3. Lykkesfeldt J. Malondialdehyde as a biomarker of oxidative damage to lipids caused by smoking. Clin Chim Acta 2007; 380: 50-58. (Pubitemid 46498044)
4. Munnia A, Bonassi S, Verna A et al. Bronchial malondialdehyde DNA adducts, tobacco smoking, and lung cancer. Free Rad Biol Med 2006; 41: 149-150.
5. Dröge W. Free radicals in the physiological control of cell function. Physiol Rev 2002; 82: 47-95. (Pubitemid 34654215)
6. Nordberg J, Arner ESJ. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Rad Biol Med 2001; 31: 1287-1312. (Pubitemid 33145299)
7. Yildirim M, Inaloz HS, Baysal V et al. The role of oxidants and antioxidants in psoriasis. J Eur Acad Dermatol Venereol 2003; 17: 34-36. (Pubitemid 36163651)
8. Van der Vaart H, Postma DS, Timens W et al. Acute effects of cigarette smoke on inflammation and oxidative stress: a review. Thorax 2004; 59: 713-721. (Pubitemid 39061538)
9. Higgins E. Alcohol, smoking and psoriasis. Clin Exp Dermatol 2000; 25: 107-110.
10. Naldi L, Chatenoud L, Linder D et al. Cigarette smoking, body mass index and stressful life events as risk factors for psoriasis: results from Italian case-control study. J Inves Dermatol 2005; 125: 61-67. (Pubitemid 40981424)
11. Setty AR, Curhan G, Choi HK. Smoking and the risk of psorisis in women: nurses' health study II. Am J Med 2007; 120: 953-959. (Pubitemid 350011082)
12. Chirico S, Smith C, Marchant MJ et al. Lipid peroxidation in hyperlipidaemic patients. A study of plasma using an HPLC-based thiobarbituric acid test. Free Radic Res Commun 1993; 19: 51.
13. Nebot C, Moutet M, Huet P et al. Spectrophotometric assay of superoxide dismutase activity based on the activated autoxidation of a tetracyclic catechol. Anal Biochem 1993; 214: 442-452.
14. Petrie A, Sabin C Basic techniques for analyzing data. In Aviva P, Caroline S, eds. Medical Statistics at a Glance, 2nd edn. BlackWell publishing, Massachusetts, USA, 2005: 46-64.
15. Seifert O, Holmberg J, Linnarsson BM. Decreased activity of neutrophil glutathione peroxidase in chronic plaque-type psoriasis. J Am Acad Dermatol 2007; 57: 528-529. (Pubitemid 47239134)
16. Baz K, Cimen MY, Kokturk A et al. Oxidant?antioxidant status in patients with psoriasis. Yonsei Med J 2003; 44: 987-990. (Pubitemid 38081563)
17. Muscat JE, Kleinman W, Colosimo S et al. Enhanced protein glutathiolation and oxidative stress in cigarette smokers. Free Rad Biol Med 2004; 36: 464-470. (Pubitemid 38224518)
18. Yanbaeva DG, Dentener MA, Creutzberg EC et al. Systemic effects of smoking. Chest 2007; 131: 1557-1566. (Pubitemid 46762366)
19. Burke A, FitzGerald GA. Oxidative stress and smoking-induced vascular injury. Prog Cardio Diseases 2003; 46: 79-90. (Pubitemid 37013220)
20. Bell LM, Sedlack R, Beard CM et al. Incidence of psoriasis in Rochester, Minn, 1980-1983. Arch Dermatol 1991; 127: 1184-1187.
21. Herron MD, Hinckley M, Hoffman MS et al. Impact of obesity and smoking on psoriasis presentation and management. Arch Dermatol 2005; 141: 1527-1534. (Pubitemid 41815842)
22. Fortes C, Mastoeni S, Leffondre K et al. Relationship between smoking and the clinical severity of psoriasis. Arch Dermatol 2005; 141: 1580-1584. (Pubitemid 41815850)
23. Pujari VM, Suryakar AN, Ireddy S. Oxidants and antioxidant status in psoriasis patients. Biomed Res 2010; 21: 221-223.
24. Popov I, Lewin G. A deficient function of the antioxidative system of the organism as an aetiopathogenetic factor in psoriasis. Med Hypotheses 1991; 35: 229-236.
25. Severin E, Nave B, Stander M et al. Total antioxidant capacity is normal in sera from psoriatic patients despite elevated Bilirubin, tocopherol crystals and urate levels. Dermatol 1999; 198: 336-339. (Pubitemid 29335724)
26. Górnicki A, Gutsze A. In vivo and in vitro influence of etretinate on erythrocyte membrane fluidity. Eur J Pharmacol 2001; 423: 127-134.
27. Relhan V, Gupta SK, Dayal S et al. Blood thiols and malondialdehyde levels in psoriasis. J Dermatol 2002; 29: 399-403. (Pubitemid 34857572)
28. Utaş S, Ktise K, Yazici C et al. Antioxidant potential of propylthiouracil in patients with psoriasis. Clin Biochem 2002; 35: 241-246. (Pubitemid 34634187)
29. Dogan P, Soyuer U, Tanrikulu G. Superoxide dismutase and myloperoxidase in polymorphonuclear leukocytes and serum ceruloplasmin and copper levels in psoriasis. Br J Dermatol 1989; 120: 239-244. (Pubitemid 19055426)
30. Kural VB, Orem A, Cimş it G et al. Evaluation of the atherogenic tendency of lipids and lipoprotein content and their relationships with oxidant-antioxidant system in patients with psoriasis. Clin Chim Acta 2003; 328: 71-82.
31. Rocha-Pereira P, Santos-Silva A, Rebelo I et al. Dyslipidemia and oxidative stress in mild and severe psoriasis as a risk for cardiovascular disease. Clin Chim Acta 2001; 303: 33-39. (Pubitemid 32121803)
32. Garg N, Singh R, Dixit J et al. Levels of lipid peroxides and antioxidants in smokers and nonsmokers. J Peridont Res 2006; 41: 405-410. (Pubitemid 44337255)
33. Orosz Z, Csiszar A, Labinskyy N et al. Cigarette smoke-induced proinflammatory alterations in the endothelial phenotype: role of NAD (P) H oxidase activation. Am J Physiol Heart Circ Physiol 2007; 292: H130-139.
34. Robbins CS, Dawe DE, Goncharova SI et al. Cigarette smoke decreases pulmonary dendritic cells and impacts antiviral immune responsiveness. Am J Respir Cell Mol Biol 2004; 30: 202-211. (Pubitemid 38147205)
35. Moszczynski P, Zabinski Z, Moszczynski P et al. Immunological findings in cigarette smokers. Toxicol Lett 2001; 118: 121-127. (Pubitemid 32008403)
36. Costenbader KH, Feskanich D, Mandl LA et al. Smoking intensity, duration, and cessation, and the risk of rheumatoid arthritis in women. Am J Med 2006; 119: e501-509.
37. Flisiak I, Chodynicka B, Porebski P et al. Association between psoriasis severity and transforming growth factor beta(1) and beta (2) in plasma and scales from psoriatic lesions. Cytokine 2002; 19: 121-125.
38. Ryder MI, Saghizadeh M, Ding Y et al. Effects of tobacco smoke on the secretion of interleukin-1beta, tumor necrosis factor-alpha, and transforming growth factor-beta from peripheral blood mononuclear cells. Oral Microbiol Immunol 2002; 17: 331-336. (Pubitemid 36058766)
39. Behnam SM, Behnam SE, Koo JY. Smoking and psoriasis. Skinmed 2005; 4: 174-176.
40. Barclay L, Lie D. Current and past smoking linked to incidence of psoriasis. Am J Med 2007; 120: 953-959.
41. Hamminga EA, van der Lely AJ, Neumann HA et al. Chronic inflammation in psoriasis and obesity: implications for therapy. Med Hypotheses 2006; 67: 768-773. (Pubitemid 44062144)